Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2) trial: baseline characteristics and comparison to other relevant clinical trials.
Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure (FAIR-HF2) trial: baseline characteristics and comparison to other relevant clinical trials.
Anker SD, Friede T, Butler J, Talha KM, Placzek M, [...], Laugwitz KL, Ponikowski P, Karakas M (2025). European Journal of Heart Failure.
